ArticleFrontiers in immunology2021

PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients.

Ran Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.